Fertility preservation for women undergoing breast cancer treatment: A postcode lottery?

Affiliations

¹ North Bristol NHS Trust, Bristol, UK.
² Poole General Hospital, Dorset, UK.
³ Department of Oncology & Metabolism, Academic Unit of Reproductive and Developmental Medicine, Sheffield, UK.
⁴ School of Medicine, University of Western Australia, Perth, WA, Australia.

Isabella Dash et al. Breast J. 2020 Oct.

. 2020 Oct;26(10):2117-2118.

doi: 10.1111/tbj.14002. Epub 2020 Aug 9.

¹ North Bristol NHS Trust, Bristol, UK.
² Poole General Hospital, Dorset, UK.
³ Department of Oncology & Metabolism, Academic Unit of Reproductive and Developmental Medicine, Sheffield, UK.
⁴ School of Medicine, University of Western Australia, Perth, WA, Australia.

No abstract available

Keywords: breast cancer; clinical commissioning group; cryopreservation; eligibility; fertility preservation.

References

1. November WP. The Effects of Cancer Treatment on Reproductive Functions Guidance on Management. 2007https://www.rcr.ac.uk/system/files/publication/field_publication_files/Cancer_fe.... Accessed September 20, 2019.
1. Peate M, Meiser B, Hickey M, Friedlander M. The fertility‐related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat. 2009;116(2):215‐223.
1. Ruddy KJ, Gelber SI, Tamimi RM, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32(11):1151‐1156.
1. RA and NZC of R (RANZCR). Optimal Care Pathway for Women with Breast Cancer. 2016:17. http://www.cancer.org.au/content/ocp/health/optimal‐care‐pathway‐for‐wom.... Accessed May 4, 2020.
1. Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994‐2001.